We are live on ! Find out more
TBA

Train Babcock Advisors Portfolio holdings

AUM $227M
1-Year Est. Return 26.2%
This Fund
S&P 500
This Quarter Est. Return
+5.43%
1 Year Est. Return
+26.2%
3 Year Est. Return
+41.88%
5 Year Est. Return
10 Year Est. Return
AUM
$249M
AUM Growth
-$2.33M
Cap. Flow
-$13.6M
Cap. Flow %
-5.47%
Top 10 Hldgs %
33.9%
Holding
124
New
8
Increased
19
Reduced
63
Closed
5

Top Buys

Rank Stock Value
1
MAS icon
Masco
MAS
+$3.02M
2
WAB icon
Wabtec
WAB
+$2.86M
3
CHKP icon
Check Point Software Technologies
CHKP
+$1.98M
4
FTV icon
Fortive
FTV
+$757K
5
BBH icon
VanEck Biotech ETF
BBH
+$312K

Top Sells

Rank Stock Value
1
PVH icon
PVH
PVH
+$4.16M
2
EFX icon
Equifax
EFX
+$3.84M
3
DOV icon
Dover
DOV
+$3.74M
4
HAIN icon
Hain Celestial
HAIN
+$3.45M
5
JLL icon
Jones Lang LaSalle
JLL
+$1.99M

Sector Composition

Rank Sector Weight
1 Technology 20.48%
2 Miscellaneous 19.92%
3 Healthcare 16.19%
4 Communication Services 9.76%
5 Financials 7.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFE icon
76
Pfizer
PFE
$159B
$556K 0.22%
17,322
+1,264
+8% +$42.3K
DOV icon
77
Dover
DOV
$26.8B
$538K 0.22%
9,037
-64,641
-88% -$3.74M
ABT icon
78
Abbott
ABT
$195B
$529K 0.21%
12,525
+180
+1% +$7.71K
KO icon
79
Coca-Cola
KO
$386B
$527K 0.21%
12,450
-100
-0.8% -$4.38K
MCD icon
80
McDonald's
MCD
$188B
$518K 0.21%
4,485
IYH icon
81
iShares US Healthcare ETF
IYH
$3.74B
$511K 0.21%
17,000
-125
-0.7% -$3.82K
KHC icon
82
Kraft Heinz
KHC
$30.5B
$504K 0.2%
5,631
BMY icon
83
Bristol-Myers Squibb
BMY
$136B
$486K 0.2%
9,008
+210
+2% +$13.5K
RDS.A
84
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$462K 0.19%
9,556
-179
-2% -$8.75K
MO icon
85
Altria Group
MO
$115B
$448K 0.18%
7,084
DIS icon
86
Walt Disney
DIS
$187B
$441K 0.18%
4,751
-300
-6% -$28.7K
ECON icon
87
Columbia Emerging Markets Consumer ETF
ECON
$316M
$439K 0.18%
17,682
-870
-5% -$21.4K
IWS icon
88
iShares Russell Mid-Cap Value ETF
IWS
$15.8B
$438K 0.18%
5,700
HUB.B
89
DELISTED
HUBBELL INC CL-B
HUB.B
$431K 0.17%
4,000
CAT icon
90
Caterpillar
CAT
$368B
$424K 0.17%
4,774
+99
+2% +$8.1K
IBB icon
91
iShares Biotechnology ETF
IBB
$10.5B
$383K 0.15%
3,969
+15
+0.4% +$1.43K
AVY icon
92
Avery Dennison
AVY
$13.5B
$373K 0.15%
4,800
VCR icon
93
Vanguard Consumer Discretionary ETF
VCR
$6.04B
$362K 0.15%
2,875
EVHC
94
DELISTED
Envision Healthcare Holdings Inc
EVHC
$360K 0.14%
5,391
-284
-5% -$19.6K
DWX icon
95
State Street SPDR S&P International Dividend ETF
DWX
$527M
$321K 0.13%
8,703
-230
-3% -$8.38K
BBH icon
96
VanEck Biotech ETF
BBH
$460M
$315K 0.13%
+2,735
New +$312K
EMR icon
97
Emerson Electric
EMR
$86.6B
$305K 0.12%
5,600
PEG icon
98
Public Service Enterprise Group
PEG
$36.5B
$301K 0.12%
7,200
CMCSA icon
99
Comcast
CMCSA
$96B
$295K 0.12%
8,906
+270
+3% +$8.99K
PEP icon
100
PepsiCo
PEP
$193B
$281K 0.11%
2,580
+130
+5% +$14K

Similar funds

Train Babcock Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Train Babcock Advisors held 124 positions worth $249M, down 0.93% from $252M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Train Babcock Advisors withdrew a net $13.6M in Q3 2016, closing 5 positions and reducing 63 holdings. Its most notable exit was PVH, an estimated $4.16M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Miscellaneous and Healthcare.

Against the trend, Train Babcock Advisors opened a new position in Masco worth $3M.

  • Train Babcock Advisors's largest Q3 2016 buy was Masco: 87,305 shares worth $3M.
  • Train Babcock Advisors added most to Check Point Software Technologies in Q3 2016, an estimated $1.98M increase.
  • Train Babcock Advisors's biggest Q3 2016 reduction was Equifax, cutting an estimated $3.84M.
  • Train Babcock Advisors fully exited PVH in Q3 2016, selling an estimated $4.16M.
  • Train Babcock Advisors's ten largest holdings make up 34% of its $249M portfolio in Q3 2016.
  • Train Babcock Advisors opened 8 new positions and closed 5 in Q3 2016.
  • Train Babcock Advisors's portfolio value fell 0.93% quarter-over-quarter to $249M.

Based on Train Babcock Advisors's 13F filing for Q3 2016, filed 21 Oct 2016.